Literature DB >> 27093608

The Correlation between Intraoperative Microelectrode Recording and 3-Tesla MRI in Patients Undergoing ANT-DBS for Refractory Epilepsy.

Timo Möttönen1, Jani Katisko, Joonas Haapasalo, Timo Tähtinen, Antti Saastamoinen, Jukka Peltola, Juha Öhman, Kai Lehtimäki.   

Abstract

BACKGROUND: Deep brain stimulation (DBS) of the anterior nucleus of the thalamus) (ANT) has been suggested as a treatment option in refractory epilepsy. The targeting of ANT is especially challenging due to its poor visualization in commonly used MRI sequences, lack of easily observable symptom relief during surgery and high degree of anatomical variation between individuals.
OBJECTIVES: To study whether intraoperative microelectrode recording (MER), a method widely used in movement disorder surgery, provides clinically relevant information during the ANT-DBS implantation procedure.
METHODS: A total of 186 MER samples from 5 patients and 10 thalami obtained from ANT-DBS surgery for refractory epilepsy were analyzed with respect to the signal characteristics and location in 3-tesla (3T) MRI STIR (short T1 inversion recovery) images. The location of each MER sample was calculated relative to visible borders of the ANT after correction of the sample locations according to the position of the final DBS electrode in postoperative CT-MRI fusion images.
RESULTS: We found that the lateral aspect of the ANT lacked spiking activity consistent with the presence of white matter. The spike frequency in samples correlating with location at the ANT showed significantly lower spike frequency compared to samples correlating with location at the ventral anterior nucleus (median 3.0 and 7.0 spikes/2 s; p < 0.05), but spike bursts were morphologically similar in appearance. Trajectories entering the dorsomedial nucleus according to 3T MRI STIR images showed a yet different firing pattern with more low-amplitude regular activity.
CONCLUSIONS: Our data suggest that MER provides clinically relevant information during implantation surgery by demonstrating both nucleus-specific neuronal firing patterns and white matter laminae between different nuclear groups.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27093608     DOI: 10.1159/000444761

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  6 in total

1.  ASSFN Position Statement on Deep Brain Stimulation for Medication-Refractory Epilepsy.

Authors:  Abhijeet Gummadavelli; Dario J Englot; Jason M Schwalb; Chengyuan Wu; Jorge Gonzalez-Martinez; Joseph Niemat; Jason L Gerrard
Journal:  Neurosurgery       Date:  2022-05-01       Impact factor: 5.315

2.  Neurophysiological Characterization of Thalamic Nuclei in Epileptic Anaesthetized Patients.

Authors:  Lorena Vega-Zelaya; Cristina V Torres; Marta Navas; Jesús Pastor
Journal:  Brain Sci       Date:  2019-11-07

3.  Estimation of ANT-DBS Electrodes on Target Positioning Based on a New PerceptTM PC LFP Signal Analysis.

Authors:  Elodie Múrias Lopes; Ricardo Rego; Manuel Rito; Clara Chamadoira; Duarte Dias; João Paulo Silva Cunha
Journal:  Sensors (Basel)       Date:  2022-09-01       Impact factor: 3.847

4.  Bilateral stereotactic lesions and chronic stimulation of the anterior thalamic nuclei for treatment of pharmacoresistant epilepsy.

Authors:  A R Sitnikov; Yu A Grigoryan; L P Mishnyakova
Journal:  Surg Neurol Int       Date:  2018-07-19

5.  Immunotherapy by targeting of VGKC complex for seizure control and prevention of cognitive impairment in a mouse model of epilepsy.

Authors:  Zhiliang Fan; Xiaojuan Feng; Zhigang Fan; Xingyuan Zhu; Shaohua Yin
Journal:  Mol Med Rep       Date:  2018-05-09       Impact factor: 2.952

6.  Direct Targeting of the Anterior Nucleus of the Thalamus via 3 T Quantitative Susceptibility Mapping.

Authors:  Kaijia Yu; Zhiwei Ren; Tao Yu; Xueyuan Wang; Yongsheng Hu; Song Guo; Jianyu Li; Yongjie Li
Journal:  Front Neurosci       Date:  2021-07-05       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.